In addition, in both cancer cell lines, azilsartan exerted a significant (p < 0.001, p < 0.01) increase in the levels of cleaved caspase 3 protein in non-stimulated and 20 ng/mL TNFα-stimulated cells, respectively, compared to the corresponding untreated cells. This evidence concerns the gene CASP3 and cancer.